2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
US-12565476-B2 · Mar 3, 2026 · US
This page is not indexed by search engines while we improve data quality.
Patent family 59383648
This patent family groups 6 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 59383648 |
| Family type | — |
| Earliest priority | Jul 12, 2016 |
| First filing country | US |
| Member publications | 6 |
| Countries | US |
| Representative publication | US12565476B2 — 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors |
Representative publication
Best representative member for this family based on priority and filing country.
US12565476B2 — 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors (published Mar 3, 2026)
Member publications
Related publications in this family.
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors
US-2024116878-A1 · Apr 11, 2024 · US
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
US-11661401-B2 · May 30, 2023 · US
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors
US-2021101870-A1 · Apr 8, 2021 · US
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
US-10590090-B2 · Mar 17, 2020 · US
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors
US-2019210977-A1 · Jul 11, 2019 · US